The recognition that phosphate-associated toxicity, especially seen in CKD, is at least partially accomplished by intermediate steps, like the formation of CPPs, in particular CPP2, and FGF23, provides the opportunity to address these intermediates instead of, or besides, phosphate only. This evidence concerns the gene FGF23 and chronic kidney disease.